ISACSON CHRISTINA K. 4
4 · Magenta Therapeutics, Inc. · Filed Feb 12, 2020
Insider Transaction Report
Form 4
ISACSON CHRISTINA K.
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-10+50,000→ 50,000 totalExercise: $12.28Exp: 2030-02-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.